Please use this identifier to cite or link to this item:
Title: ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
Issue Date: 2015
Citation: PLoS ONE.2015;(10)12:e0144004
Abstract: Whether inosine triphosphatase (ITPA) gene polymorphisms predict anemia during interferon-free therapy in chronic hepatitis C virus (HCV)-infected patients is unknown. We examined the relationship between two ITPA polymorphisms, anemia, and sustained virological response 12 weeks post-treatment (SVR12) in patients receiving the NS3/4A protease inhibitor faldaprevir, the non-nucleoside polymerase inhibitor deleobuvir, and ribavirin.
PMID: 26650626
Rights: openAccess
Appears in Collections:Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC4674133.pdf382,77 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.